Nucleic Acids Research, 1994, Vol. 22, No. 25 5665-5671
© 1994
Articles |
Transcriptional regulation of the apoAl gene by hepatic nuclear factor 4 in yeast
Department of Cardiovascular Molecular Biology, Lederle Laboratories 401 N. Middletown Road, American Cyanamid Co., Pearl River, NY 10965, USA
*To whom correspondence should be addressed
Received August 23, 1994. Revised October 24, 1994. Accepted October 24, 1994.
Hepatocyte Nuclear Factor 4 (HNF-4), a liver-enriched orphan receptor of the nuclear receptor superfamlly, is required for the expression of a wide variety of liver-specific genes including apoAl. To explore the possibility that site A of the apoAl gene enhancer might also be the target for HNF-4 without the interference of endogenous mamalian cell proteins that also bind to site A, we tested the ability of HNF-4 to activate transcription from site A in yeast cells. Electrophoretlc mobility shift assays (EMSA) and Scatchard plot analysis demonstrated that yeast produced HNF-4 binds to site A with an affinity two times higher than that of yeast produced RXRa. Mapping analysis indicated that the 5' portion of site A containing two Imperfect direct repeats (TGAACCCTTGACC) and the sequence of the trinucleotide spacer (CCT) between these Imperfect repeats are critical determinants for selective binding and transactlvation by HNF-4. Similar observations were obtained when these mutated versions of site A were evaluated by transient cotransfection assays in CV1 cells. We conclude that the unique structural determinants of site A in conjunction with the differential binding affinity of HNF-4 for site A may play a fundamental role In apoAl gene regulation.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. M. Sladek, M. D. Ruse Jr., L. Nepomuceno, S.-M. Huang, and M. R. Stallcup Modulation of Transcriptional Activation and Coactivator Interaction by a Splicing Variation in the F Domain of Nuclear Receptor Hepatocyte Nuclear Factor 4alpha 1 Mol. Cell. Biol., October 1, 1999; 19(10): 6509 - 6522. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fraser, D. Keller, V. Martinez, D. Santiso-Mere, R. Straney, and M. R. Briggs Utilization of Recombinant Adenovirus and Dominant Negative Mutants to Characterize Hepatocyte Nuclear Factor 4-regulated Apolipoprotein AI and CIII Expression J. Biol. Chem., May 23, 1997; 272(21): 13892 - 13898. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Giffin, J. Kwast-Welfeld, D. J. Rodda, G. G. Prefontaine, M. Traykova-Andonova, Y. Zhang, N. L. Weigel, Y. A. Lefebvre, and R. J.G. Hache Sequence-specific DNA Binding and Transcription Factor Phosphorylation by Ku Autoantigen/DNA-dependent Protein Kinase. PHOSPHORYLATION OF Ser-527 OF THE RAT GLUCOCORTICOID RECEPTOR J. Biol. Chem., February 28, 1997; 272(9): 5647 - 5658. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Harnish, S. Malik, E. Kilbourne, R. Costa, and S. K. Karathanasis Control of Apolipoprotein AI Gene Expression through Synergistic Interactions between Hepatocyte Nuclear Factors 3and 4 J. Biol. Chem., June 7, 1996; 271(23): 13621 - 13628. [Abstract] [Full Text] [PDF] |
||||

